Delivery Order SPE2DB22D3501-SPE2DB25FWK29
Award Date 7/14/25
Potential Completion Date 7/15/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a Delivery Order by the Defense Logistics Agency (DLA) on July 17, 2025, for the supply of 500 tablets of Ondansetron HCl 4 mg, with a contract ceiling value of $14,504.96. The contract utilizes firm fixed pricing and is scheduled for completion by July 18, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp will perform this delivery order from its corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a $8,219.46 delivery order contract by the Defense Logistics Agency on September 24, 2025, for the supply of Ondansetron HCL 4 mg tablets (30-count units). This firm fixed-price contract, with an ultimate completion date of September 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating the contractor's continued...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,258.95 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a $11,793.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,256,298 units of Ondansetron HCL 4 mg tablets. The order has a completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $31,456.95 by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of 500 tablets of Ondansetron HCl 4 mg. This competitive award, utilizing firm fixed-price pricing, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. The delivery order carries no set-aside designation, indicating it was awarded through open competition. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,013.50 for Ondansetron Orally Disintegrating Tablets 8mg (30-count supply) on August 21, 2025, with completion targeted for September 18, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $2,872.80 by the Department of Defense Medical Supply Chain on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation. This award is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $14,466.96 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a ceiling value of $13,637.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,834.54 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count packaging) on August 15, 2025, with completion expected by August 18, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...